vs
Apellis Pharmaceuticals, Inc.（APLS）与MGIC INVESTMENT CORP（MTG）财务数据对比。点击上方公司名可切换其他公司
MGIC INVESTMENT CORP的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$298.7M vs $199.9M），MGIC INVESTMENT CORP净利率更高（56.7% vs -29.5%，领先86.2%），MGIC INVESTMENT CORP同比增速更快（-0.9% vs -5.9%），MGIC INVESTMENT CORP自由现金流更多（$230.2M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 0.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
MGIC投资集团（纽交所代码：MTG）是美国专业的私人抵押贷款保险服务商，总部位于威斯康星州密尔沃基市，主要为美国本土住房抵押贷款业务提供保险解决方案，帮助贷款机构管控信用风险，助力普通消费者顺利获得购房贷款支持。
APLS vs MTG — 直观对比
营收规模更大
MTG
是对方的1.5倍
$199.9M
营收增速更快
MTG
高出5.0%
-5.9%
净利率更高
MTG
高出86.2%
-29.5%
自由现金流更多
MTG
多$244.4M
$-14.3M
两年增速更快
APLS
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $298.7M |
| 净利润 | $-59.0M | $169.3M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 71.2% |
| 净利率 | -29.5% | 56.7% |
| 营收同比 | -5.9% | -0.9% |
| 净利润同比 | -62.2% | -8.3% |
| 每股收益（稀释后） | $-0.40 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMTG
| Q4 25 | $199.9M | $298.7M | ||
| Q3 25 | $458.6M | $304.5M | ||
| Q2 25 | $178.5M | $304.2M | ||
| Q1 25 | $166.8M | $306.2M | ||
| Q4 24 | $212.5M | $301.4M | ||
| Q3 24 | $196.8M | $306.6M | ||
| Q2 24 | $199.7M | $305.3M | ||
| Q1 24 | $172.3M | $294.4M |
净利润APLSMTG
| Q4 25 | $-59.0M | $169.3M | ||
| Q3 25 | $215.7M | $191.1M | ||
| Q2 25 | $-42.2M | $192.5M | ||
| Q1 25 | $-92.2M | $185.5M | ||
| Q4 24 | $-36.4M | $184.7M | ||
| Q3 24 | $-57.4M | $200.0M | ||
| Q2 24 | $-37.7M | $204.2M | ||
| Q1 24 | $-66.4M | $174.1M |
营业利润率APLSMTG
| Q4 25 | -25.6% | 71.2% | ||
| Q3 25 | 48.7% | 77.2% | ||
| Q2 25 | -18.6% | 80.9% | ||
| Q1 25 | -50.0% | 76.6% | ||
| Q4 24 | -12.3% | 77.9% | ||
| Q3 24 | -24.0% | 82.9% | ||
| Q2 24 | -14.7% | 85.1% | ||
| Q1 24 | -36.0% | 74.7% |
净利率APLSMTG
| Q4 25 | -29.5% | 56.7% | ||
| Q3 25 | 47.0% | 62.8% | ||
| Q2 25 | -23.6% | 63.3% | ||
| Q1 25 | -55.3% | 60.6% | ||
| Q4 24 | -17.1% | 61.3% | ||
| Q3 24 | -29.2% | 65.2% | ||
| Q2 24 | -18.9% | 66.9% | ||
| Q1 24 | -38.5% | 59.1% |
每股收益（稀释后）APLSMTG
| Q4 25 | $-0.40 | $0.75 | ||
| Q3 25 | $1.67 | $0.83 | ||
| Q2 25 | $-0.33 | $0.81 | ||
| Q1 25 | $-0.74 | $0.75 | ||
| Q4 24 | $-0.30 | $0.71 | ||
| Q3 24 | $-0.46 | $0.77 | ||
| Q2 24 | $-0.30 | $0.77 | ||
| Q1 24 | $-0.54 | $0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $369.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $5.1B |
| 总资产 | $1.1B | $6.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSMTG
| Q4 25 | $466.2M | $369.0M | ||
| Q3 25 | $479.2M | $266.9M | ||
| Q2 25 | $370.0M | $294.9M | ||
| Q1 25 | $358.4M | $207.0M | ||
| Q4 24 | $411.3M | $229.5M | ||
| Q3 24 | $396.9M | $288.6M | ||
| Q2 24 | $360.1M | $281.8M | ||
| Q1 24 | $325.9M | $431.3M |
总债务APLSMTG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSMTG
| Q4 25 | $370.1M | $5.1B | ||
| Q3 25 | $401.2M | $5.2B | ||
| Q2 25 | $156.3M | $5.2B | ||
| Q1 25 | $164.2M | $5.1B | ||
| Q4 24 | $228.5M | $5.2B | ||
| Q3 24 | $237.1M | $5.3B | ||
| Q2 24 | $264.3M | $5.1B | ||
| Q1 24 | $266.7M | $5.1B |
总资产APLSMTG
| Q4 25 | $1.1B | $6.6B | ||
| Q3 25 | $1.1B | $6.6B | ||
| Q2 25 | $821.4M | $6.5B | ||
| Q1 25 | $807.3M | $6.5B | ||
| Q4 24 | $885.1M | $6.5B | ||
| Q3 24 | $901.9M | $6.7B | ||
| Q2 24 | $904.5M | $6.5B | ||
| Q1 24 | $831.9M | $6.5B |
负债/权益比APLSMTG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $230.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $230.2M |
| 自由现金流率自由现金流/营收 | -7.1% | 77.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.2% |
| 现金转化率经营现金流/净利润 | — | 1.36× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $851.8M |
8季度趋势，按日历期对齐
经营现金流APLSMTG
| Q4 25 | $-14.2M | $230.8M | ||
| Q3 25 | $108.5M | $215.4M | ||
| Q2 25 | $4.4M | $183.0M | ||
| Q1 25 | $-53.4M | $223.7M | ||
| Q4 24 | $19.4M | $182.4M | ||
| Q3 24 | $34.1M | $182.9M | ||
| Q2 24 | $-8.3M | $169.2M | ||
| Q1 24 | $-133.0M | $190.5M |
自由现金流APLSMTG
| Q4 25 | $-14.3M | $230.2M | ||
| Q3 25 | $108.3M | $215.1M | ||
| Q2 25 | $4.4M | $183.0M | ||
| Q1 25 | $-53.4M | $223.5M | ||
| Q4 24 | $19.3M | $181.9M | ||
| Q3 24 | — | $182.5M | ||
| Q2 24 | $-8.4M | $169.0M | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSMTG
| Q4 25 | -7.1% | 77.1% | ||
| Q3 25 | 23.6% | 70.6% | ||
| Q2 25 | 2.5% | 60.1% | ||
| Q1 25 | -32.0% | 73.0% | ||
| Q4 24 | 9.1% | 60.3% | ||
| Q3 24 | — | 59.5% | ||
| Q2 24 | -4.2% | 55.3% | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSMTG
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.0% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率APLSMTG
| Q4 25 | — | 1.36× | ||
| Q3 25 | 0.50× | 1.13× | ||
| Q2 25 | — | 0.95× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 1.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MTG
暂无分部数据
